These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2471805)

  • 1. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18.
    Stokes A; Allen GP; Pullen LA; Murray PK
    J Gen Virol; 1989 May; 70 ( Pt 5)():1173-83. PubMed ID: 2471805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.
    Stokes A; Corteyn AH; Pullen LA; Doel TR; Meredith DM; Killington RA; Halliburton IW; Whittaker GR; Wheldon LA; Nicolson L
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():923-31. PubMed ID: 1707948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
    Tsujimura K; Yamanaka T; Kondo T; Fukushi H; Matsumura T
    J Vet Med Sci; 2006 Oct; 68(10):1029-38. PubMed ID: 17085880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulating complexes (ISCOMs) containing the major viral glycoproteins.
    Cook RF; O'Neill T; Strachan E; Sundquist B; Mumford JA
    Vaccine; 1990 Oct; 8(5):491-6. PubMed ID: 2174599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the major glycoproteins of equine herpesviruses 4 and 1 and asinine herpesvirus 3 using monoclonal antibodies.
    Crabb BS; Allen GP; Studdert MJ
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2075-82. PubMed ID: 1716650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model.
    Tewari D; Whalley JM; Love DN; Field HJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1735-41. PubMed ID: 8021602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model.
    Azmi M; Field HJ
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.
    Sinclair R; Moult BJ; Mumford JA
    Arch Virol; 1993; 129(1-4):327-36. PubMed ID: 7682404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine profiles and long-term virus-specific antibodies following immunization of CBA mice with equine herpesvirus 1 and viral glycoprotein D.
    Zhang Y; Smith PM; Frampton AR; Osterrieder N; Jennings SR; O'Callaghan DJ
    Viral Immunol; 2003; 16(3):307-20. PubMed ID: 14583146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
    Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.
    Guo PX; Goebel S; Perkus ME; Taylor J; Norton E; Allen G; Languet B; Desmettre P; Paoletti E
    J Virol; 1990 May; 64(5):2399-406. PubMed ID: 2157895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies with neutralizing activity to equine herpesvirus 1.
    Shimizu M; Satou K; Nishioka N
    Arch Virol; 1989; 104(1-2):169-74. PubMed ID: 2538111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of T-cells, virus neutralising antibodies and complement-mediated antibody lysis in the immune response against equine herpesvirus type-1 (EHV-1) infection of C3H (H-2k) and BALB/c (H-2d) mice.
    Alber DG; Greensill J; Killington RA; Stokes A
    Res Vet Sci; 1995 Nov; 59(3):205-13. PubMed ID: 8588092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells.
    Azmi M; Field HJ
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():275-80. PubMed ID: 8381468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells presenting equine herpesvirus-1 antigens induce protective anti-viral immunity.
    Steinbach F; Borchers K; Ricciardi-Castagnoli P; Ludwig H; Stingl G; Elbe-Bürger A
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():3005-14. PubMed ID: 9880015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
    Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge.
    Stokes A; Alber DG; Cameron RS; Marshall RN; Allen GP; Killington RA
    Virus Res; 1996 Oct; 44(2):97-109. PubMed ID: 8879139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.